Aug 11, 2022 Mustang Bio Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights
Jul 27, 2022 Mustang Bio Announces First Patient Successfully Treated by Ex Vivo Lentiviral Gene Therapy to Treat RAG1 Severe Combined Immunodeficiency